secwatch / observer
8-K filed November 9, 2023, 6:59 PM ET ticker TDG CIK 0001260221
earnings confidence high sentiment positive materiality 0.85

TransDigm Q4 adj EPS $8.03 (+46% YoY); declares $35 special dividend; to buy CPI Electron Device for $1.385B

TransDigm Group INC

2023-FY EPS reported $22.03 revenue$6,585,000,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

TransDigm Group INC reported fiscal year ended September 30, 2023 results: revenue $6,585 million, net income $1,299 million, EPS $22.03.

Period
fiscal year ended September 30, 2023
Revenue
$6,585 million
Net income
$1,299 million
EPS
$22.03
Result
reported results
Exact text from the filing
Fiscal 2023 highlights include: • Net sales of $6,585 million, up 21% from $5,429 million in the prior fiscal year; • Income from continuing operations of $1,299 million, up 50% from the prior fiscal year; • Earnings per share from continuing operations of $22.03, up 65% from the prior fiscal year;
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

TransDigm Group INC reported fourth quarter ended September 30, 2023 results: revenue $1,852 million, net income $414 million, EPS $7.23.

Period
fourth quarter ended September 30, 2023
Revenue
$1,852 million
Net income
$414 million
EPS
$7.23
Result
reported results
Exact text from the filing
Fourth quarter highlights include: • Net sales of $1,852 million, up 23% from $1,510 million in the prior year's quarter; • Income from continuing operations of $414 million, up 56% from the prior year's quarter; • Earnings per share from continuing operations of $7.23, up 82% from the prior year's quarter;
View on SEC.gov

Browse all earnings releases →

TransDigm Group INC filing history →

Source: SEC EDGAR
accession 0001260221-23-000077
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.